6F., No. 244, Sec. 3, Chengde Rd., Datong Dist., Taipei City 103, Taiwan tgcc@greencross.com.tw
Overview

Three strategic axes, a healthcare link spanning three continents

With Taiwan as our headquarters and distribution hub, we have built three strategic axes — import, export and business development:
distributing quality products from international manufacturers in Spain, the United States, Germany and other countries; exporting our contract-manufactured Urokinase to Asia-Pacific markets such as Hong Kong, Singapore and Malaysia; and continuing to explore new cooperation opportunities in Japan and other regions.

Every partnership we build centres on patient medication safety, forming a green network of life that spans three continents.

Map of Taiwan Green Cross global partnership markets
Import|Partnerships with international manufacturers
Export|Asia-Pacific export markets
Import

Partnerships with international manufacturers

ES · Import

Spain

Partner|Grifols

Distributor of Grifols-branded products, serving as a stable gateway for international manufacturers entering Taiwan.

US · Import

United States

Partner|Grifols

Distributor of Grifols-branded products, serving as a stable gateway for international manufacturers entering Taiwan.

DE · Import

Germany

Partner|Kreussler

Project-based import cooperation with a German manufacturer, establishing a stable supply relationship.

FR · Import

France

Partner|Alamed Aesthetics

Import cooperation with a French manufacturer, establishing a stable supply relationship.

Export

Asia-Pacific export markets

TW · Headquarters

Taiwan

Founded 1969|Distribution hub

Home to our headquarters, leading the global distribution of Urokinase 60,000 IU and bringing a range of international brands into the Taiwan market.

HK · Export

Hong Kong

Since 2008|Urokinase

A key export market for our contract-manufactured Urokinase, and the pivotal starting point for the brand's entry into Greater China.

SG · Export

Singapore

Since 2009|Urokinase

An important Southeast Asian market that plays a steady role in our Asia-Pacific export footprint.

MY · Export

Malaysia

Export market|Urokinase

An important Southeast Asian market that plays a steady role in our Asia-Pacific export footprint.

VN · Export

Vietnam

Since 2012|Urokinase

A key market in our southbound strategy, where cooperation across Southeast Asia continues to deepen.

TH · Export

Thailand

Since 2013|Urokinase

Launched in Thailand in 2013, strengthening brand visibility across Southeast Asia.

MM · Export

Myanmar

Since 2015|Urokinase

An important Southeast Asian market and an early presence in an emerging market.